2026/0119 - 040101162026 - Ajuste direto para aquisição de T1140 - TRIPTORRELINA (PÓ P/ SOL INJ) [0.1 MG/ML; 1 ML; FRS] e T202 - TRIPTORRELINA (PÓ P/ SUSP INJ) [3,75MG; FRS/ SERINGA] para suprir necessidades na área da saúde.

ID 12598939 · Portal BASE
Price
Base Price
€18,450 .00
Effective Price
€83 .00 -99.6%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Coimbra, Coimbra
Bidder Count
—
Winner
IPSEN PORTUGAL - PRODUTOS FARMACEUTICOS S.A.
NIF 502609800
Company
Dates
Publication
16 Jan 2026
Celebration
09 Jan 2026
Contracting Entity
Centro Hospitalar e Universitário de Coimbra, EPE
NIF 510103448
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 10 · LOW RISK
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
18450.0
Total effective price
83.0
Ratio
0.0045
Direction
reduction
Rule
A9 price reduction: ratio 0.0045 outside [0.5, 1.5]
Detected 2026-03-06